Health Care Equipment & Services

Guardant Health CEO’s $4.18 buys amid a $150‑plus rally show confidence in long‑term upside and tactical liquidity, hinting at a bullish future.

LifeStance insider Bessler sells 894k shares at $10.13, yet keeps large holdings—showing confidence while capturing gains.

Insider buying & selling at Beta Bionics signals mixed confidence; CFO’s recent $5.10 purchase amid volatile $17 stock suggests short‑term hedging while backing long‑term iLet pipeline.

Sim Brandon’s June 27 sale of 1,093 ASTRANA Health shares is a tax‑hedge, not a confidence drop, as the company’s strong rally and insider buying signal bullish prospects.

Insightful insider sale recap: EVP Michael Feld sold 75 BD shares at $152.80—routine liquidity, steady holdings, and a neutral signal for investors.

OMADA Health CEO Sean Duffy’s steady, low‑volume sales reveal a disciplined, rule‑based trading plan that keeps long‑term confidence intact.

OMADA Health insider sales stay low‑volume and rule‑compliant, hinting at confidence rather than distress—investors can gauge future filing patterns for clues.

Mark Hancock’s disciplined insider sales at PACS Group show routine rebalancing, not a sell‑off warning, while the stock’s 224 % YTD surge keeps investors intrigued.

Axogen insider RSU buys reveal board confidence in nerve‑regeneration strategy, suggesting potential upside for investors despite growth‑phase metrics.

Phreesia insider buying shows confidence in long‑term growth, with a director’s recent purchase hinting at strategic upside for health‑tech investors.